{
    "title": "Expanding Opportunities for Recovery Act of 2014",
    "content": "SECTION 1. SHORT TITLE.\n\n    This Act may be cited as the ``Expanding Opportunities for Recovery \nAct of 2014''.\n\nSEC. 2. OPIOID ADDICTION TREATMENT.\n\n    (a) In General.--The Administrator of the Substance Abuse and \nMental Health Services Administration, acting through the Director of \nthe Center for Substance Abuse Treatment (in this section referred to \nas the ``Administrator'') shall award grants to States to expand access \nto clinically appropriate services for opioid abuse, dependence, or \naddiction.\n    (b) Requirements.--As conditions on the receipt of a grant under \nthis section, a State shall agree to comply with the following:\n            (1) The grant will be administered through the head of the \n        State's primary agency responsible for programs and activities \n        relating to the treatment of substance abuse.\n            (2) The services through the grant will be evidence-based \n        such as medication-assisted treatment for substance use \n        disorder.\n            (3) The services through the grant will be provided \n        according to a physician or a clinician's recommendation to \n        ensure that individuals receive the optimal level of substance \n        use disorder treatment for the amount of time that is deemed \n        medically necessary.\n            (4) The services through the grant will be provided \n        exclusively to individuals--\n                    (A) who lack health insurance; or\n                    (B) whose health insurance--\n                            (i) does not cover such services; or\n                            (ii) places other barriers on the receipt \n                        of such services, such as--\n                                    (I) limiting coverage of such \n                                services to a certain period of time; \n                                or\n                                    (II) imposing non-quantitative \n                                treatment limitations that are more \n                                stringent than treatment limitations \n                                imposed on other medical conditions \n                                (such as a requirement to use less \n                                expensive services, like out-patient \n                                treatment, prior to more expensive, but \n                                physician-recommended services, such as \n                                in-patient or residential treatment).\n            (5) The grant will not be used to pay or subsidize the cost \n        of more than 60 consecutive days of opioid abuse, dependence, \n        or addiction treatment in the case of any individual.\n    (c) Permissible Provision of Medications.--In expanding access to \nclinically appropriate services for opioid abuse, dependence, or \naddiction through a grant under this section, a State may provide for \nthe use of medications, in conjunction with other treatment, so long \nas--\n            (1) the medications are lawfully marketed under the Federal \n        Food, Drug, and Cosmetic Act (21 U.S.C. 301 et seq.);\n            (2) are clinically indicated to address the abuse, \n        dependence, or addiction; and\n            (3) are offered consistent with consumer choice.\n    (d) Coordination.--The Administrator shall coordinate the program \nunder this section with the program for prevention and treatment of \nsubstance abuse under subpart II of part B of title XIX of the Public \nHealth Service Act (42 U.S.C. 300x-21 et seq.).\n    (e) Evaluation; Dissemination of Information; Technical \nAssistance.--\n            (1) In general.--The Administrator shall--\n                    (A) require States receiving a grant under this \n                section to report appropriate outcome measures \n                associated with use of the grant, including any--\n                            (i) decreases in substance use;\n                            (ii) changes in retention in care;\n                            (iii) connections to the next appropriate \n                        level of care;\n                            (iv) decreases in involvement with criminal \n                        justice activities; and\n                            (v) other outcome data as appropriate;\n                    (B) require States receiving a grant under this \n                section to report data on individuals' length of time \n                under clinically appropriate addiction treatment, and \n                the use of medication-assisted treatment;\n                    (C) evaluate the activities supported by grants \n                under this section;\n                    (D) submit to the Congress and the Secretary, and \n                make publicly available on the Internet site of the \n                Substance Abuse and Mental Health Services \n                Administration, information about the results of such \n                evaluation; and\n                    (E) offer technical assistance to States receiving \n                a grant under this section regarding activities funded \n                through the grant.\n            (2) Use of certain funds.--Of the funds appropriated to \n        carry out this section for any fiscal year, 5 percent shall be \n        available to carry out activities under this subsection."
}